Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2000
05/11/2000WO2000026238A2 Biological materials and methods useful in the diagnosis and treatment of prion diseases
05/11/2000WO2000026227A1 Ldl related protein and uses thereof
05/11/2000WO2000026216A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors
05/11/2000WO2000026208A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/11/2000WO2000026205A1 Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level
05/11/2000WO2000026204A1 Novel optically active aminopentane derivative
05/11/2000WO2000026203A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000WO2000026202A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000WO2000026201A1 Benzoylpyridazines
05/11/2000WO2000026199A2 Use of n-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives as selective mglur1 antagonists
05/11/2000WO2000026198A1 N-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives, their preparation and their use as selective mglur1 antagonists
05/11/2000WO2000026192A1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
05/11/2000WO2000025798A1 Treatment of parkinson's disease with oligonucleotides
05/11/2000WO2000025793A1 Compositions for the treatment and prevention of neurological and pathopsychological diseases
05/11/2000WO2000025791A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
05/11/2000WO2000025790A1 Controlled delivery of antidepressants
05/11/2000WO2000025788A1 Inhibitors of prenyl-protein transferase
05/11/2000WO2000025787A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000WO2000025786A1 Heterocyclic potassium channel inhibitors
05/11/2000WO2000025783A1 Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder
05/11/2000WO2000025779A1 Method of treating migraines and pharmaceutical compositions
05/11/2000WO2000025778A1 5ht1 receptor agonists and metoclopramide for the treatment of migraine
05/11/2000WO2000025777A1 SUBSTITUTED PHENETHYLSULFONES AND METHOD OF REDUCING TNFαLEVELS
05/11/2000WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
05/11/2000WO2000025774A1 Benzamide potassium channel inhibitors
05/11/2000WO2000025770A1 Carbocyclic potassium channel inhibitors
05/11/2000WO2000025769A1 Analgesic regimen
05/11/2000WO2000025767A2 Use of triphenylbutene derivatives for the treatment of neurological disorders
05/11/2000WO2000025753A2 Controlled delivery of active agents
05/11/2000WO2000025752A1 Multiparticulate modified release composition
05/11/2000WO2000013648A8 Method for the preparation of citalopram
05/11/2000WO2000013015A8 Modulating multiple lineage kinase proteins
05/11/2000WO2000012710A8 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same
05/11/2000WO2000008007A3 Cyclopentabenzofuran derivatives and their use
05/11/2000WO2000007542A3 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance p
05/11/2000WO1999053036A3 Ste20-related protein kinases
05/11/2000DE19851758A1 Use of corticosteroids and/or addictive drugs or their pharmacodynamic equivalents to prepare medicaments for treating drug addiction
05/11/2000DE19851179A1 Verwendung von Extrakten von Eschscholzia californica zur Herstellung von Arzneimitteln zur Behandlung von Depressionen Use of extracts of Eschscholzia californica for the preparation of medicaments for the treatment of depression
05/11/2000DE19850701A1 Benzoylpyridazine Benzoylpyridazine
05/11/2000CA2653839A1 Multiparticulate modified release composition
05/11/2000CA2350212A1 Treatment of parkinson's disease with oligonucleotides
05/11/2000CA2350052A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000CA2349818A1 Membrane transport proteins
05/11/2000CA2349567A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors
05/11/2000CA2349482A1 Pharmaceutical compounds
05/11/2000CA2349444A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
05/11/2000CA2349232A1 Benzoylpyridazines
05/11/2000CA2349158A1 Compounds and methods for modulating claudin-mediated functions
05/11/2000CA2348979A1 Method of treating migraines and pharmaceutical compositions
05/11/2000CA2348907A1 Analgesic regimen
05/11/2000CA2348751A1 Biological materials and methods useful in the diagnosis and treatment of diseases
05/11/2000CA2348728A1 Method for the production of quercetin and isoquercetin derivatives
05/11/2000CA2348703A1 Inhibitors of prenyl-protein transferase
05/11/2000CA2348543A1 5ht1 receptor agonists and metoclopramide for the treatment of migraine
05/11/2000CA2348446A1 Benzamide potassium channel inhibitors
05/11/2000CA2347855A1 Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder
05/11/2000CA2347650A1 Transmembrane 4 proteins
05/11/2000CA2347188A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000CA2347102A1 Compounds with growth hormone releasing properties
05/11/2000CA2347060A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000CA2317117A1 Ldl related protein and uses thereof
05/11/2000CA2312430A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/10/2000EP0999205A1 Aminocycloalkane compounds
05/10/2000EP0998916A1 Medicinal compositions for application to mucosa
05/10/2000EP0998495A1 Amyloid beta protein (globular assembly and uses thereof)
05/10/2000EP0998494A1 Pompilid wasp-derived neuropeptides
05/10/2000EP0998474A1 Piperazine derivatives
05/10/2000EP0998471A1 Substituted heterocyclic compounds, method for preparing and compositions containing same
05/10/2000EP0998460A1 Novel tetrazole derivatives
05/10/2000EP0998459A2 Pyridine derivatives
05/10/2000EP0998294A1 Ganglioside gm3 induced apoptosis of neural cells
05/10/2000EP0998288A1 Compositions containing capsaicin or capsaicin analogues and a local anesthetic
05/10/2000EP0998286A2 Use of levobupivacaine
05/10/2000EP0998281A1 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
05/10/2000EP0998276A1 Use of alkanoyl carnitine derivatives for the treatment of attention-deficit/hyperactive disorders
05/10/2000EP0800503B1 Novel trienoic retinoid compounds and methods
05/10/2000EP0763031B1 Piperazine derivatives as 5ht1a antagonists
05/10/2000EP0743939B1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
05/10/2000EP0736004B1 (2,4-disulfophenyl) n-tertiary butyl nitrone, its salts, and their use as pharmaceutical radical trapping agents
05/10/2000EP0703781B1 Use of efaroxan and derivatives thereof for the preparation of a medicament for the treatment of parkinson's disease
05/10/2000CN1252799A N-heterocyclic derivatives as NOS inhibitor
05/10/2000CN1252798A Indazole amide compounds as 5-serotoninergic agents
05/10/2000CN1252793A 4-aminoalkoxy-1H-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor D2 agonists
05/10/2000CN1252725A Analgesic combination
05/10/2000CN1252720A Gastric-retained pharmaceutical compositions
05/10/2000CN1252705A Sustained analgesia achieved with buprenorphine
05/10/2000CN1252415A Powdered rubber powder containing modified filler, its preparing method and its use
05/10/2000CN1252302A Drugging-abstaining and physique enhancing Chinese medicine
05/10/2000CN1052239C Method for preparation of NTPS
05/10/2000CN1052218C Process for preparing substituted 2-amino tetrahydronaphthalenes and 3-aminochromans
05/10/2000CN1052164C Chinese medicinal preparation for senile dementia
05/10/2000CN1052158C Pure traditional Chinese medicine santhasan for curing headache and its preparing method
05/09/2000US6060508 Benzylamine derivatives, their preparation and their application in therapeutics
05/09/2000US6060506 Benzopyran derivatives as melatonergic agents
05/09/2000US6060504 Administering heat stable crystal form of kappa-opiate agonist asimadoline hydrochloride to treat inflammatory gastrointestinal disorders and simultaneously relieve pain with side effect reduction
05/09/2000US6060499 Concurrently administering mixture of long-acting non-steroidal antiinflammatory drug (la-nsaid) with 5ht agonist to reduce relapse
05/09/2000US6060494 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
05/09/2000US6060487 Indanol compounds
05/09/2000US6060482 Serotonin inhibitors
05/09/2000US6060479 Quinazoline-4-one AMPA antagonists
1 ... 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 ... 1833